Statin use and the five-year incidence and progression of age-related macular degeneration (Q36007005)

11 August 2017

Statin use and the five-year incidence and progression of age-related macular degeneration (English)

1 reference

11 August 2017

1 reference

Ronald Klein

1

1 reference

11 August 2017

Michael D Knudtson

series ordinal

2

1 reference

11 August 2017

Barbara E K Klein

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

2 May 2007

1 reference

American Journal of Ophthalmology

11 August 2017

1 reference

11 August 2017

144

1 reference

11 August 2017

1

1 reference

11 August 2017

1-6

1 reference

Ranibizumab for neovascular age-related macular degeneration

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

A case control study of age related macular degeneration and use of statins.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

Risk factors for age-related maculopathy: the Visual Impairment Project

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

Risk of macular degeneration in users of statins: cross sectional study.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

Accumulation of cholesterol with age in human Bruch's membrane.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

The role of oxidative stress in the pathogenesis of age-related macular degeneration.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

The Beaver Dam Eye Study: visual acuity

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

The Wisconsin age-related maculopathy grading system

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

Risk factors for incident age-related macular degeneration: pooled findings from 3 continents

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1988696

23 September 2018

1 reference

12 December 2020

Changes in visual acuity in a population over a 10-year period : The Beaver Dam Eye Study

1 reference

12 December 2020

Cholesterol-lowering medications reduce the risk of age-related maculopathy progression

1 reference

12 December 2020

The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group

1 reference

12 December 2020

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

1 reference

12 December 2020

Changes in visual acuity in a population. The Beaver Dam Eye Study

1 reference

12 December 2020

The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study

1 reference

12 December 2020

3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study

1 reference

12 December 2020

Changes in Visual Acuity in a Population Over a 15-year Period: The Beaver Dam Eye Study

1 reference

12 December 2020

10.1016/J.AJO.2007.02.047

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

17475196

1 reference